Who we are
Innovata, a then privately owned South African Pharmaceutical company, was started in the year 2000 with its office situated in Roshnee, Vereeniging, Johannesburg. At the time of its inception, Innovata predominantly focussed on servicing the Public Sector, producing essential medicines for the South African population as well as exporting to various African countries. These mainly consisted of anti-infectives, analgesic as well as cough and cold medicines. Innovata also catered for a smaller private market.
By 2012, Innovata had grown to such an extend and was then incorporated into a larger international, healthcare group i.e. Avacare Health. It has become the group’s leading pharmaceutical subsidiary. Since its acquisition by Avacare Health, Innovata has intensified its acquisition of pharmaceutical products (orthodox and non-orthodox) and currently boasts a pipeline of over 120 niche products submitted in South Africa and various other African countries.Innovata’s products has become household names in the large public sector of South Africa and the rest of the African continent.
Innovata is made up of 6 staff members.
What we do
Over the years, Innovata grew organically, acquiring newer molecules and increasing its product basket to provide for a broader pharmacological spectrum and over larger markets, both public and private sectors. The products spanned over the entire dosage form range and included tablets, capsules, powders for suspensions, creams and injectables.
What we offer
Innovata provides high quality, affordable pharmaceutical products.
It outsources the manufacturing of its products to both locally and international GMP compliant/ WHO approved manufacturing facilities.
Exporting of products to various African countries.
Doing research and development on new products/molecules.
Submit products for registration/ marketing authorisation in South Africa and other African countries.